X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (45) 45
oncology (42) 42
humans (32) 32
melanoma (29) 29
tumors (22) 22
article (17) 17
cancer (17) 17
immunotherapy (17) 17
middle aged (17) 17
male (16) 16
aged (14) 14
clinical trials (14) 14
female (14) 14
adult (11) 11
metastasis (11) 11
patients (11) 11
apoptosis (10) 10
chemotherapy (10) 10
ipilimumab (10) 10
mutation (10) 10
aged, 80 and over (9) 9
animals (9) 9
cancer therapies (9) 9
care and treatment (9) 9
metastatic melanoma (9) 9
medical research (8) 8
melanoma - pathology (8) 8
mice (8) 8
safety (8) 8
solid tumors (8) 8
survival (8) 8
drug therapy (7) 7
medicine & public health (7) 7
neoplasms - drug therapy (7) 7
open-label (7) 7
pembrolizumab (7) 7
toxicity (7) 7
treatment outcome (7) 7
analysis (6) 6
antibodies, monoclonal, humanized - therapeutic use (6) 6
biomarkers (6) 6
braf (6) 6
cell lung-cancer (6) 6
expression (6) 6
immunology (6) 6
melanoma - drug therapy (6) 6
metastases (6) 6
pharmacology (6) 6
therapy (6) 6
angiogenesis (5) 5
antibodies, monoclonal, humanized - adverse effects (5) 5
antineoplastic agents - adverse effects (5) 5
dermatology (5) 5
glutamate (5) 5
health aspects (5) 5
inhibition (5) 5
maximum tolerated dose (5) 5
melanoma - genetics (5) 5
neoplasms - pathology (5) 5
nivolumab (5) 5
pd-1 blockade (5) 5
prognosis (5) 5
research (5) 5
skin neoplasms - pathology (5) 5
antineoplastic agents - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
antitumor activity (4) 4
autophagy (4) 4
cell line, tumor (4) 4
cell proliferation - drug effects (4) 4
cells (4) 4
complications and side effects (4) 4
ctla-4 blockade (4) 4
fatigue (4) 4
gene expression (4) 4
growth (4) 4
immunohistochemistry (4) 4
malignant-melanoma (4) 4
medicine (4) 4
melanoma - metabolism (4) 4
molecular targeted therapy (4) 4
multicenter (4) 4
neoplasms - genetics (4) 4
neoplasms. tumors. oncology. including cancer and carcinogens (4) 4
pd-l1 (4) 4
pharmacokinetics (4) 4
prostate cancer (4) 4
proteins (4) 4
proto-oncogene proteins b-raf - genetics (4) 4
receptors, metabotropic glutamate - metabolism (4) 4
skin cancer (4) 4
trial (4) 4
vemurafenib (4) 4
1-phosphatidylinositol 3-kinase (3) 3
akt protein (3) 3
anti-pd-l1 antibody (3) 3
anticancer properties (3) 3
antineoplastic agents, immunological - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
autophagy - genetics (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 12/2017, Volume 35, Issue 34, pp. 3823 - 3829
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e21029 - e21029
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 3021 - 3021
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 5_suppl, pp. 104 - 104
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 6617 - 6617
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 5_suppl, pp. TPS80 - TPS80
Journal Article
12/2015, 1st ed. 2016, Cancer Treatment and Research, ISBN 3319225383, Volume 167, 413
Melanoma is one of the most types of cancer. When melanoma is detected at an early stage, treatment is highly successful, but outcomes can be poor when the... 
Oncology | Pediatrics | Medicine & Public Health | Dermatology | Surgery | Melanoma
eBook
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 4081 - 4081
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. 9019 - 9019
Journal Article
Cancer Treatment and Research, ISSN 0927-3042, 2016, Volume 167, pp. 295 - 320
Mucosal melanoma is an exceedingly rare variant of cutaneous melanoma that, due to its rarity, is poorly described and infrequently studied. Primary sites of... 
Imatinib | Targeted | Mucosal | Immunotherapy | KIT | Melanoma | BRAF | Melanoma - etiology | Prognosis | Skin Neoplasms - therapy | Melanoma - genetics | Humans | Skin Neoplasms - genetics | Skin Neoplasms - etiology | Mutation | Melanoma - therapy | Molecular Targeted Therapy
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. e20003 - e20003
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e55096
Journal Article
2016, 1st ed. 2016., Cancer Treatment and Research, ISBN 3319225391, Volume 167
Melanoma is one of the most types of cancer. When melanoma is detected at an early stage, treatment is highly successful, but outcomes can be poor when the... 
Medicine | Pediatrics | Dermatology | Surgery | Oncology
Web Resource
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. TPS9093 - TPS9093
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. TPS3095 - TPS3095
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. e19069 - e19069
Journal Article
Cancer Research, ISSN 0008-5472, 04/2012, Volume 72, Issue 8 Supplement, pp. 2276 - 2276
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.